U.s. Supreme Court 2011 Term Arguments

Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S

Informações:

Sinopse

A case in which the Court held that counterclaims that challenge unpatented uses of generic drugs, even if other approved uses are still under patent, are allowable under the Hatch-Waxman Act.